Page 222 - IJB-9-2

International Journal of Bioprinting Three-dimensional bioprinting in toxicological research

toxicity assessment of nanoparticles in a HepG2 liver studies of primycin-sulphate using a three-dimensional (3D)
spheroid model. Nanomaterials (Basel), 10: 545. in vitro human liver aggregate model. Toxicol Lett, 281: 44–52.
https://doi.org/10.3390/nano10030545 https://doi.org/10.1016/j.toxlet.2017.09.005
47. Flores-Torres S, Peza-Chavez O, Kuasne H, et al., 2021, 58. Lancaster MA, Knoblich JA, 2014, Organogenesis in a
Alginate-gelatin-matrigel hydrogels enable the development dish: Modeling development and disease using organoid
and multigenerational passaging of patient-derived 3D technologies. Science, 345: 1247125.
bioprinted cancer spheroid models. Biofabrication 13: 025001.
https://doi.org/10.1126/science.1247125
https://doi.org/10.1088/1758-5090/abdb87
59. Simian M, Bissell MJ, 2017, Organoids: A historical perspective
48. Gunti S, Hoke AT, Vu KP, et al., 2021, Organoid and spheroid of thinking in three dimensions. J Cell Biol, 216: 31–40.
tumor models: Techniques and applications. Cancers (Basel), https://doi.org/10.1083/jcb.201610056
13: 874.
60. Fatehullah A, Tan SH, Barker N, 2016, Organoids as an
https://doi.org/10.3390/cancers13040874
in vitro model of human development and disease. Nat Cell
49. Kim SJ, Kim EM, Yamamoto M, et al., 2020, Engineering Biol, 18: 246–254.
multi-cellular spheroids for tissue engineering and https://doi.org/10.1038/ncb3312
regenerative medicine. Adv Healthc Mater, 9: e2000608.
61. Skottvoll FS, Hansen FA, Harrison S, et al., 2021,
https://doi.org/10.1002/adhm.202000608
Electromembrane extraction and mass spectrometry
50. Proctor WR, Foster AJ, Vogt J, et al., 2017, Utility of spherical for liver organoid drug metabolism studies. Anal Chem,
human liver microtissues for prediction of clinical drug- 93: 3576–3585.
induced liver injury. Arch Toxicol, 91: 2849–2863.
https://doi.org/10.1021/acs.analchem.0c05082
https://doi.org/10.1007/s00204-017-2002-1
62. Nuciforo S, Heim MH, 2021, Organoids to model liver
51. Wang Z, Luo X, Anene-Nzelu C, et al., 2015, HepaRG culture disease. JHEP Rep, 3: 100198.
in tethered spheroids as an in vitro three-dimensional model
for drug safety screening. J Appl Toxicol, 35: 909–917. https://doi.org/10.1016/j.jhepr.2020.100198
63. Zhu M, Huang Y, Bian S, et al., 2020, Organoid: Current
https://doi.org/10.1002/jat.3090
implications and pharmaceutical applications in liver
52. Hendriks DF, Vorrink SU, Smutny T, et al., 2020, Clinically diseases. Curr Mol Pharmacol, 14: 498–508.
relevant cytochrome P450 3A4 induction mechanisms and https://doi.org/10.2174/1874467213666201217115854
drug screening in three-dimensional spheroid cultures
of primary human hepatocytes. Clin Pharmacol Ther, 64. Messina A, Luce E, Hussein M, et al., 2020, Pluripotent-
108: 844–855. stem-cell-derived hepatic cells: Hepatocytes and organoids
for liver therapy and regeneration. Cells, 9: 420.
https://doi.org/10.1002/cpt.1860
https://doi.org/10.3390/cells9020420
53. Ingelman-Sundberg M, Lauschke VM, 2021, 3D human liver
spheroids for translational pharmacology and toxicology. 65. Kim J, Koo BK, Knoblich JA, 2020, Human organoids:
Basic Clin Pharmacol Toxicol, 130: 5–15. model systems for human biology and medicine. Nat Rev
Mol Cell Biol, 21: 571–584.
https://doi.org/10.1111/bcpt.13587
https://doi.org/10.1038/s41580-020-0259-3
54. Sant S, Johnston PA, 2017, The production of 3D tumor
spheroids for cancer drug discovery. Drug Discov Today 66. Driehuis E, Kretzschmar K, Clevers H, 2020, Establishment
Technol, 23: 27–36. of patient-derived cancer organoids for drug-screening
applications. Nat Protoc, 15: 3380–3409.
https://doi.org/10.1016/j.ddtec.2017.03.002
https://doi.org/10.1038/s41596-020-0379-4
55. Hurrell T, Ellero AA, Masso ZF, et al., 2018, Characterization
and reproducibility of HepG2 hanging drop spheroids 67. Corro C, Novellasdemunt L, Li VS, 2020, A brief history of
toxicology in vitro. Toxicol In Vitro, 50: 86–94. organoids. Am J Physiol Cell Physiol, 319: C151–C165.
https://doi.org/10.1016/j.tiv.2018.02.013 https://doi.org/10.1152/ajpcell.00120.2020
56. Pinto B, Henriques AC, Silva PMA, et al., 2020, Three- 68. Prior N, Inacio P, Huch M, 2019, Liver organoids: from basic
dimensional spheroids as in vitro preclinical models for research to therapeutic applications. Gut, 68: 2228–2237.
cancer research. Pharmaceutics, 12: 1186. https://doi.org/10.1136/gutjnl-2019-319256
https://doi.org/10.3390/pharmaceutics12121186
69. Mun SJ, Ryu JS, Lee MO, et al., 2019, Generation of expandable
57. Penzes A, Abdelwahab EM, Rapp J, et al., 2017, Toxicology human pluripotent stem cell-derived hepatocyte-like liver

Volume 9 Issue 2 (2023) 214 https://doi.org/10.18063/ijb.v9i2.663